PF 2021-21 Extension of Suspension for Drug Testing Requirements for Federal Drug Testing Personnel

Memorandum from the Acting Secretary, Extension of Suspension for Drug Testing Requirements for Federal Testing Personnel.

Office of Management

March 3, 2021

DATE: March 3, 2021

SUBJECT: Further Extension of the National Interest Action code for COVID-19

TO: HCAs/Procurement Directors/Contracting Officers

FROM: Director, Contract and Financial Assistance Policy Division, Office of Policy, Office of Acquisition Management

SUMMARY: Policy Flash 2021 – 21 provides the attached Memorandum from theActing Secretary, Extension of Suspension for Drug Testing Requirements for Federal Testing Personnel.

Contracting Officers shall provide notification of the Secretarial Memorandum to contractors that are subject to the requirements contained in the Memorandum.

For DOE questions concerning this policy flash, please email: DOE_oapmpolicy@hq.doe.gov

For NNSA questions concerning this policy flash, please contact NNSA at (505) 845-4337.

_{«Back to Policy Flashes}

Memorandum - Extension of Suspension for Drug Testing Requirements for Federal Drug Testing Personnel.pdf
PF 2021-21 Extension of Suspension and Exercise of Enforcement Discretion for Certain Safety and Security Requirements and Requirements During the Ongoing COVID-19 Pandemic

Extension of Suspension and Exercise of Enforcement Discretion for Certain Safety and Security Requirements and Requirements During the Ongoing COVID-19 Pandemic
PF 2021-21 Extension of Security Exercise Requirements and Authority for Under Secretaries to Extend Certain Security Requirements Due to Coronavirus Disease 2019

Extension of Security Exercise Requirements and Authority for Under Secretaries to Extend Certain Security Requirements Due to Coronavirus Disease 2019